(S (NP (NP (DT The) (NN dose) (NN regimen)) (PP (IN of) (NP (NNP Warfarin)))) (VP (VBZ is) (VP (VBN separated) (PP (IN into) (NP (CD two) (NNS phases))))) (. .))
(S (ADVP (RB Firstly)) (NP (DT a) (NN loading) (NN dose)) (VP (VBZ is) (VP (VBN given) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN designed) (S (VP (TO to) (VP (VB bring) (NP (NP (DT the) (JJ International) (NN Normalisation) (NN Ratio)) (-LRB- -LRB-) (NP (NN INR)) (-RRB- -RRB-)) (PP (IN to) (PP (IN within) (NP (JJ therapeutic) (NN range))))))))))))) (. .))
(S (ADVP (RB Then)) (NP (DT a) (JJ stable) (NN maintenance) (NN dose)) (VP (VBZ is) (VP (VBN given) (S (VP (TO to) (VP (VB maintain) (NP (DT the) (NN INR)) (PP (IN within) (NP (JJ therapeutic) (NN range)))))))) (. .))
(S (PP (IN In) (NP (DT the) (NNP United) (NNP Kingdom) (PRN (-LRB- -LRB-) (NP (NNP UK)) (-RRB- -RRB-)))) (NP (DT the) (NN loading) (NN dose)) (VP (VBZ is) (ADVP (RB usually)) (VP (VBN given) (PP (IN as) (NP (NP (CD three) (JJ individual) (JJ daily) (NNS doses)) (, ,) (NP (DT the) (JJ standard) (NN loading) (NN dose)))) (S (VP (VBG being) (NP (NP (NP (NP (CD 10) (NNS mg)) (PP (IN on) (NP (NNS days) (CD one) (CC and) (CD two)))) (CC and) (NP (NP (NNS 5mgs)) (PP (IN on) (NP (NN day) (CD three))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB be) (VP (VBN varied) (PP (IN at) (NP (NP (DT the) (NN discretion)) (PP (IN of) (NP (DT the) (NN clinician))))))))))))))) (. .))
(S (ADVP (RB However)) (, ,) (PP (IN due) (PP (IN to) (NP (NP (DT the) (JJ large) (JJ inter-individual) (NN variation)) (PP (IN in) (NP (NP (DT the) (NN response)) (PP (IN to) (NP (NN Warfarin) (NN therapy)))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ difficult) (S (VP (TO to) (VP (VB identify) (SBAR (SBAR (WHNP (WDT which)) (S (NP (NNS patients)) (VP (MD will) (VP (VB reach) (NP (DT the) (JJ narrow) (JJ therapeutic) (NN window)) (PP (IN for) (NP (NN target) (NN INR))))))) (, ,) (CC and) (SBAR (WHNP (WDT which)) (S (VP (MD will) (VP (VB be) (PP (IN above) (CC or) (IN below) (NP (DT the) (JJ therapeutic) (NN window))))))))))))) (. .))
(S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT this) (NN research)))) (VP (VBD was) (S (VP (TO to) (VP (VB develop) (NP (NP (DT a) (NN methodology)) (VP (VBG using) (NP (NP (DT a) (NML (NML (JJ neural) (NNS networks)) (NN classification)) (NN algorithm)) (CC and) (NP (NML (NNS data) (NN mining)) (NNS techniques))) (S (VP (TO to) (VP (VB predict) (PP (IN for) (NP (NP (DT a) (VBN given) (NN loading) (NN dose)) (CC and) (NP (JJ patient) (NNS characteristics))))))) (SBAR (IN if) (S (NP (DT the) (NN patient)) (VP (VBZ is) (ADJP (ADJP (RBR more) (JJ likely) (S (VP (TO to) (VP (VB achieve) (NP (NN target) (NN INR)))))) (CC or) (ADJP (RBR more) (JJ likely) (S (VP (TO to) (VP (VB be) (PP (IN above) (CC or) (IN below) (NP (JJ therapeutic) (NN range))))))))))))))))) (. .))
(S (NP (NP (JJ Multilayer) (NN perceptron) (PRN (-LRB- -LRB-) (NP (NN MLP)) (-RRB- -RRB-))) (CC and) (NP (RB 10-fold) (ADJP (JJ stratified)) (NN cross) (NN validation) (NNS algorithms))) (VP (VBD were) (VP (VBN used) (S (VP (TO to) (VP (VB determine) (NP (DT an) (JJ artificial) (JJ neural) (NN network)) (S (VP (TO to) (VP (VB classify) (NP (NP (NNS patients) (POS ')) (NN response)) (PP (IN to) (NP (PRP$ their) (JJ initial) (NML (NN Warfarin) (NN loading)) (NN dose))))))))))) (. .))
(S (NP (DT The) (VBG resulting) (NML (JJ neural) (NN network)) (NN model)) (ADVP (RB correctly)) (VP (VBZ classifies) (NP (NP (DT an) (NN individual) (POS 's)) (NN response)) (PP (IN to) (NP (NP (PRP$ their) (NML (NN Warfarin) (NN loading)) (NN dose)) (PP (IN over) (NP (NP (CD 80) (NN %)) (PP (IN of) (NP (DT the) (NN time)))))))) (. .))
(S (S (CONJP (RB As) (RB well) (IN as)) (VP (VBG taking) (PP (IN into) (NP (NP (NN account)) (NP (DT the) (JJ initial) (NN loading) (NN dose)))))) (, ,) (NP (DT the) (JJ final) (NN model)) (ADVP (RB also)) (VP (VBZ includes) (NP (NP (JJ demographic) (, ,) (JJ genetic)) (CC and) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NML (JJ other) (JJ potential)) (VBG confounding) (NNS factors)))))) (. .))
(S (PP (IN With) (NP (DT this) (NN model))) (NP (NNS clinicians)) (VP (MD can) (VP (VB predetermine) (SBAR (IN whether) (S (NP (NP (DT a) (VBN given) (NN loading) (NN regimen)) (, ,) (PP (IN along) (PP (IN with) (NP (ADJP (JJ specific) (JJ patient)) (NNS characteristics))))) (VP (MD will) (VP (VB achieve) (NP (DT a) (JJ therapeutic) (NN response)) (PP (IN for) (NP (DT a) (JJ particular) (NN patient))))))))) (. .))
(S (ADVP (RB Thus)) (VP (VP (VBG tailoring) (NP (DT the) (NN loading) (NN dose) (NN regimen)) (S (VP (TO to) (VP (VB meet) (NP (NP (DT the) (JJ individual) (NNS needs)) (PP (IN of) (NP (DT the) (NN patient)))))))) (CC and) (VP (VBG reducing) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NP (JJ adverse) (NN drug) (NNS reactions)) (VP (VBN associated) (PP (IN with) (NP (NN Warfarin))))))))) (. .))
